Leadership Team

Joni Glandon, Chief Financial Officer, has nearly 20 years of experience in finance and accounting, with the last decade focused on early phase clinical development. Ms. Glandon received her degree in Accounting and Finance from Iowa State University and has extensive experience creating financial and clinical study budgets, financial reporting and analysis and system implementations. She leads the team responsible for creating all clinical trial site budgets and ensuring that they meet the needs of our biopharmaceutical sponsors.

Beth Williams, Executive Director of Clinical Trial Services, has worked in the pharmaceutical industry for more than 13 years. Her leadership role is rooted in practical experiences developed as a project manager. Beth is responsible for key project activities including the operational conduct of studies, coordination of vendors and client communication. Beth maintains high quality, scientific and ethical standards while ensuring timely management of the study from protocol inception to CSR finalization.

Chris Hardage has over 25 years of clinical research experience with an emphasis on early clinical development and Phase 1 studies for over 20 years. His industry experience includes clinical trial coordination, project management, clinical monitoring, quality control, clinic operations and site management. Chris leverages his extensive and diversified background daily to ensure that optimal customer service is achieved throughout the client relationship.

Caitlyn Logan is an experienced industry veteran in the CRO space. She has managed multiple CRO departments including quality control, training and clinical operations. Caitlyn also holds a Lean Six Sigma Green Belt achieved in 2017 and was also part of the six-year B.A./M.D. program at UMKC where she earned her B.A. in Chemistry.

Korey Nevitt, Executive Director of Site Operations, has been in clinical research for over two decades with robust experience in operations, commercial strategy and planning and global site partnerships. Korey is responsible for the growth and expansion of our strategically aligned site partners ensuring our multi-site studies are conducted by the most capable investigators that they are aligned with our commitment to speed, customer service and delivering the highest quality data possible to our biopharmaceutical clients.

Dr. George Atiee has over 35 years of experience in clinical research and has participated as an investigator in well over 300 clinical studies. Before his role with DVCR, Dr. Atiee served in various leadership roles such as Vice President, Medical Director, Site Director and Lab Director for multiple CROs. Dr. Atiee brings a unique perspective to our organization with his ability to assess critical study paths and provide operations teams with efficient strategies for enrollment, data collection and biomedical interventions.

Dr. Preskorn is an academic physician, psychiatrist, clinical researcher, neuropsychopharmacologist and medical educator. He has worked with over 140 pharmaceutical, biotech, device and diagnostic companies and has worked on 16 successful New Drug Applications. His publications include over 500 medical papers, books and book chapters. Further, he has been cited in medical literature over 18,000 times. Dr. Preskorn has served as a consultant to the FDA, EMA and NIH and has lectured in 55 countries and at most medical schools in the US and throughout the world.